Pending EO 12866 Regulatory Review

RIN: 1117-AB40         Received Date: 06/13/2024 
Title: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation 
Agency/Subagency: DOJ / DEA   Stage: Proposed Rule 
Legal Deadline: Statutory  Section 3(f)(1) Significant: No 
International Impacts: No Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No